RDHL
RedHill Biopharma Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · IL
$0.40
−3.65%Margins
Gross margin
100.0%
EBITDA margin
-2675.5%
EBIT margin
-2765.4%
Net margin
-150.0%
FCF margin
-3376.2%
39.8%
Return on equity
-1.6%
Return on assets
—
Return on invested capital
0.01x
Asset turnover
-$9.7M
Cash from operations
$0.58
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026